Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting |
Hypercholesterolemia | Germany | |
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML |
FLT3-mutated Acute Myeloid Leukemia | Phase2 | Turkey Jordan Germany Italy Czechia Poland Slovenia Korea, Republic of Austria View All |
Study Evaluating Effectiveness and Adherence of Inclisiran Plus Standard of Care (SoC) Lipid-lowering Therapy Compared to SoC in ASCVD |
Primary Hypercholesterolemia, Mixed Dyslipidemia | United Arab Emirates Switzerland United Kingdom Austria Israel Saudi Arabia Malaysia China View All |
|
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation |
Relapsing-Remitting Multiple Sclerosis | Phase4 | United States Canada |
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation |
KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung, Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary, Pulmonary Cancer, Pulmonary Neoplasms | Phase1, Phase2 | United States Netherlands Spain China Italy Japan Denmark Germany Hong Kong Belgium France Australia Canada Korea, Republic of Singapore Taiwan View All |
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake |
Neoplasms | Phase1, Phase2 | United Kingdom France United States Netherlands Austria Spain View All |
Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria |
Uncomplicated Plasmodium Falciparum Malaria | Phase3 | Congo, The Democratic Republic of the |
WOE of Anti-CD20 Therapies |
Multiple Sclerosis | United States | |
Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity |
Retinopathy of Prematurity | Korea, Republic of | |
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. |
C3G | Phase3 | United States Greece Brazil Argentina Germany France Canada India View All |